Adverum Biotechnologies
ADVM | NASDAQ
$4.36
$0.00 (0.00%)
At close: Dec 9, 2025, 4:00 PM ET
Adverum Biotechnologies Company Profile
Company profile explainedCompany Profile
Adverum Biotechnologies, Inc. is a clinical-phase biotechnology firm primarily engaged in discovering and advancing gene therapies. The company's mission is to create innovative treatments for various eye-related conditions and uncommon illnesses. Its flagship experimental gene therapy, ADVM-022, is a potential therapy administered through a single injection into the vitreous humor of the eye. This treatment is being developed for individuals afflicted with persistent retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies maintains licensing and collaborative partnerships with institutions such as the University of California and Cornell University, as well as companies like GenSight, Lexeo, and Virovek. Established in 2006, the organization was initially named Avalanche Biotechnologies, Inc. before rebranding to Adverum Biotechnologies, Inc. in May 2016. Its headquarters are situated in Redwood City, California.
Key Executives
| Name | Position |
|---|---|
| Laurent Fischer | President, Chief Executive Officer & Director |
| Dena House | Chief People Officer |
| Kishor Peter Soparkar | Chief Operating Officer |
| Linda Rubinstein | Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer |
| R. Andrew Ramelmeier | Chief Technology Officer |
| Aneta Ferguson | General Counsel |
| Carla Fiankan | Senior Vice President of Regulatory Affairs |
| Rabia Gurses Ozden | Chief Medical Officer |
| Romuald Corbau | Chief Scientific Officer |
| Setareh Seyedkazemi | Chief Development Officer |
Adverum Biotechnologies
| Country | United States |
| IPO Date | Jul 31, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 155 |
| CEO | Laurent Fischer |
Contact Details
800 Saginaw Drive Redwood City,
California 94063 United States
Stock Details
| Ticker Symbol | ADVM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001501756 |
| CUSIP Number | 00773U207 |
| ISIN Number | US00773U2078 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove ADVM